hold on there's just too much going on in Congress lmao...
Designates March 3, 2026, as National Triple-Negative Breast Cancer Day.
Rep. Joseph Morelle (D-NY), along with four other co-sponsors.
Introduced in the House and referred to a committee.
This resolution expresses the House of Representatives' support for designating March 3, 2026, as "National Triple-Negative Breast Cancer Day." The goal is to raise awareness about this specific type of aggressive cancer and the need for action to eradicate it. Representative Joseph Morelle, a Democrat from New York, introduced the bill, and it has been sent to the House Committee on Oversight and Government Reform for review.
Introduced Mar 3, 2026
The resolution was introduced in the House of Representatives on March 3, 2026, and immediately referred to the Committee on Oversight and Government Reform. For this resolution to pass, it typically needs to be approved by this committee, then voted on by the full House. Since it's a House Resolution, it does not go to the Senate or require the President's signature; it only reflects the sentiment of the House.
If this resolution passes, you might see more public discussions, news coverage, and educational campaigns related to triple-negative breast cancer around March 3, 2026. This increased awareness could lead to better understanding of its unique characteristics, including its impact on young women and specific ethnic groups, and potentially galvanize support for research into its treatment and prevention.
Supporters Say
Supporters argue this day will raise crucial awareness for an aggressive breast cancer type and encourage action.
Critics Say
No explicit criticism is identified in the bill text for this type of resolution.
Supporters emphasize that recognizing a dedicated day will bring much-needed attention to triple-negative breast cancer, which is often more aggressive and has higher mortality rates. The bill text highlights that this cancer disproportionately affects younger women, Black and Hispanic women, and those with BRCA gene mutations, underscoring the need for targeted awareness and action. Resolutions like this generally receive bipartisan support as they aim to raise public health awareness without direct budgetary impact.